Risk Stratification and Prognostic Value of Right Ventricular Dysfunction Screening Using Transthoracic Echocardiography in Acute Pulmonary Embolism
RVD-PE
1 other identifier
observational
112
1 country
2
Brief Summary
This observational study evaluates right ventricular dysfunction in patients with acute pulmonary embolism using transthoracic echocardiography and assesses its prognostic significance and risk stratification value.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2026
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedFirst Posted
Study publicly available on registry
June 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
June 15, 2026
June 1, 2026
6 months
May 23, 2026
June 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Right ventricular dysfunction as a prognostic marker in acute pulmonary embolism
To assess the prognostic value of right ventricular dysfunction detected by transthoracic echocardiography for risk stratification in patients with acute pulmonary embolism
From hospital admission until hospital discharge, with an average duration of 7 days.
Secondary Outcomes (1)
In-hospital adverse clinical outcomes
From hospital admission until hospital discharge, with an average duration of 7 days.
Study Arms (1)
Patients with acute pulmonary embolism
Patients diagnosed with acute pulmonary embolism who undergo transthoracic echocardiographic assessment for evaluation of right ventricular dysfunction.
Interventions
Transthoracic echocardiography performed for assessment of right ventricular dysfunction in patients with acute pulmonary embolism.
Eligibility Criteria
Patients diagnosed as acute pulmonary embolism
You may qualify if:
- Patients aged 18 years and older.
- Patients with a confirmed diagnosis of acute pulmonary embolism.
- Patients who underwent transthoracic echocardiographic assessment for right ventricular dysfunction.
You may not qualify if:
- Patients younger than 18 years.
- Patients with incomplete clinical data.
- Patients who did not undergo transthoracic echocardiography.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (2)
Sohag University hospital
Sohag, Egypt
Sohag University hospital
Sohag, Egypt
Related Publications (1)
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jimenez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ni Ainle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405. No abstract available.
PMID: 31504429BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecture
Study Record Dates
First Submitted
May 23, 2026
First Posted
June 15, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
June 15, 2026
Record last verified: 2026-06